These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4097 related articles for article (PubMed ID: 22002720)

  • 1. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.
    Jia G; Fu Y; Zhao X; Dai Q; Zheng G; Yang Y; Yi C; Lindahl T; Pan T; Yang YG; He C
    Nat Chem Biol; 2011 Oct; 7(12):885-7. PubMed ID: 22002720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA.
    Fu Y; Jia G; Pang X; Wang RN; Wang X; Li CJ; Smemo S; Dai Q; Bailey KA; Nobrega MA; Han KL; Cui Q; He C
    Nat Commun; 2013; 4():1798. PubMed ID: 23653210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential m
    Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
    Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyl-adenosine modification in messenger and long non-coding RNA.
    Pan T
    Trends Biochem Sci; 2013 Apr; 38(4):204-9. PubMed ID: 23337769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.
    Huang Y; Yan J; Li Q; Li J; Gong S; Zhou H; Gan J; Jiang H; Jia GF; Luo C; Yang CG
    Nucleic Acids Res; 2015 Jan; 43(1):373-84. PubMed ID: 25452335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
    Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
    Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Specific
    Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
    Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kr├╝ppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Shan HJ; Gu WX; Duan G; Chen HL
    Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
    Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
    Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
    [No Abstract]   [Full Text] [Related]  

  • 16. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 17. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
    Relier S; Rivals E; David A
    RNA Biol; 2022; 19(1):132-142. PubMed ID: 35067178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible RNA adenosine methylation in biological regulation.
    Jia G; Fu Y; He C
    Trends Genet; 2013 Feb; 29(2):108-15. PubMed ID: 23218460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 205.